Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization
摘要:
A series of imidazo[1,2-a]pyridines which directly bind to HCV Non-Structural Protein 4B (NS4B) is described. This series demonstrates potent in vitro inhibition of HCV replication (EC50 < 10 nM), direct binding to purified NS4B protein (IC50 < 20 nM), and an HCV resistance pattern associated with NS4B (H94N/R, V105L/M, F98L) that are unique among reported HCV clinical assets, suggestive of the potential for additive or synergistic combination with other small molecule inhibitors of HCV replication.
DOI:
10.1021/ml300090x
作为产物:
描述:
3-(三氟甲基磺酰氧基)-2H-吡咯-1(5h)-羧酸叔丁酯 、 2-THIENYLZINC BROMIDE 在
四(三苯基膦)钯乙酸乙酯 、 Brine 、 Sodium sulfate-III 作用下,
以
四氢呋喃 为溶剂,
反应 1.75h,
以Column chromatography [n-hex/EtOAc (12:1 v/v)] of the crude gave 3-thiophen-2-yl-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester (49 mg, 33%) as an oil的产率得到3-(thiophen-2-yl)-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester
参考文献:
名称:
Certain nitrogen containing bicyclic chemical entities for treating viral infections
Acetamides and benzamides that are useful in treating sexual dysfunction
申请人:——
公开号:US20040029887A1
公开(公告)日:2004-02-12
The present invention relates to the use of compounds of formula (I)
1
for the treatment of sexual dysfunction and to compositions containing compounds of formula (I) for the treatment of sexual dysfunction.
本发明涉及使用式(I)的化合物治疗性功能障碍,以及含有式(I)化合物的组合物用于治疗性功能障碍。
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
申请人:Baskaran Subramanian
公开号:US20100204265A1
公开(公告)日:2010-08-12
Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
申请人:Schmitz Franz Ulrich
公开号:US20120121540A1
公开(公告)日:2012-05-17
Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).